MedPath
HSA Approval

BENOCTEN TABLET 50 mg

SIN00362P

BENOCTEN TABLET 50 mg

BENOCTEN TABLET 50 mg

April 23, 1988

DKSH SINGAPORE PTE. LTD.

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.
Licence HolderDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R06AA02

diphenhydramine

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

SIEGFRIED LTD

Rottendorf Pharma GmbH

Active Ingredients

DIPHENHYDRAMINE HCl

50 mg

Diphenhydramine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BENOCTEN TABLET 50 mg - HSA Approval | MedPath